2-(4-(2-[18F]Fluoro-2,2-Dideutero Ethyl)Piperidin-1-Yl)Benzo[4,5]Imidazo[1,2-A]Pyrimidine

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

7 Countries

Phase II

Phase II: 1

Sponsors using this IMP

UCB Biopharma 1

All trials

1 total

A study to learn if bepranemab is safe and works in people with early stages of Alzheimer’s Disease Ended

2023-506170-12-00 Phase II 7 countries UCB Biopharma

Showing 1–1 of 1 trials

← All drugs A–Z